| Not Yet Recruiting | FENOX Trial (Comparative Effectiveness of Fexuprazan Co-therapy in Patients Receiving Non-Vitamin K Antagonist NCT07497893 | Ewha Womans University Mokdong Hospital | N/A |
| Not Yet Recruiting | IMMUNO-FIT Observational Study NCT07354971 | University Hospital Southampton NHS Foundation Trust | — |
| Recruiting | A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With C NCT07169851 | Eli Lilly and Company | Phase 2 |
| Recruiting | A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects NCT07319364 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 1 |
| Not Yet Recruiting | Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patient NCT06407401 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 3 |
| Recruiting | Compliance and Tolerance to Oral AntiBiotherapy in Osteoarticular Infections (OTABIO) NCT05202964 | Hospices Civils de Lyon | — |
| Recruiting | Telenursing for the Early Detection and Management of Side Effects Associated With Cyclin-Dependent Kinase Inh NCT07524829 | Azienda Sanitaria Locale di Asti | N/A |
| Recruiting | Routinely Collected Clinical Data and Evaluation of Antimicrobial Target Attainment NCT06427317 | Imperial College London | — |
| Unknown | Applying Mobile Healthcare Education to Improve Cutaneous Self-care Capability NCT06291688 | National Taiwan University Hospital | N/A |
| Recruiting | Sex, Psychopharmacology, and Diabetes NCT05951660 | Zealand University Hospital | N/A |
| Completed | Improving Medication Prescribing-Related Outcomes for Vulnerable Elderly in Transitions NCT04077281 | St. Joseph's Healthcare Hamilton | N/A |
| Not Yet Recruiting | Individual Risk Profiles for Adverse Drug Reactions in Geriatric Patients NCT05247814 | RWTH Aachen University | — |
| Active Not Recruiting | Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer NCT05096338 | Abramson Cancer Center at Penn Medicine | — |
| Active Not Recruiting | Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast Cancer NCT05078190 | Abramson Cancer Center at Penn Medicine | — |
| Completed | Effect of a trAnSitional Pharmacist Intervention in geRiatric Inpatients on Hospitals Visits After dischargE NCT04617340 | Universitaire Ziekenhuizen KU Leuven | N/A |
| Completed | DOAC ADRs Retrospective Study on Genetic Variations NCT04580589 | Cipherome, Inc. | — |
| Unknown | Pharmacogenomics in Prediction of Cardiovascular Drugs Adverse Reaction NCT05307718 | Clinical Hospital Centre Zagreb | — |
| Completed | Association Between Genetic Variant Scores and DOACs (DARES2) NCT04597593 | Cipherome, Inc. | — |
| Terminated | DOAC ADRs Retrospective Study NCT04247919 | Cipherome, Inc. | — |
| Completed | The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial NCT02482025 | VA Office of Research and Development | N/A |
| Completed | Impact of Pharmacotherapeutic Education on Medication Adherence and Adverse Outcomes in Type 2 Diabetes NCT03438162 | University Hospital Dubrava | N/A |
| Unknown | Discontinuation of Long-term Medications in Older People Entering Nursing Home Care NCT03501108 | University College Cork | N/A |
| Completed | Effect and Associated Factors of the Clinical Pharmacy Model in the Incidence of Medical Errors NCT03338725 | Universidad de Antioquia | N/A |
| Unknown | Association of Genetic Polymorphisms With Capecitabine-based Chemotherapy Toxicities in Chinese Solid Tumor Pa NCT03258099 | Cui Yimin | — |
| Unknown | Association of Genetic Polymorphisms With Docetaxel-based Chemotherapy Toxicities in Chinese Solid Tumor Patie NCT03258151 | Cui Yimin | — |
| Completed | Neuropsychiatric Side Effects of Efavirenz in Children Living With HIV NCT03227653 | Radboud University Medical Center | — |
| Completed | Different Chemotherapy Protocols Combined With Intensity Modulated Radiation Therapy in Patients With Locally NCT03177174 | Luo yanrong | N/A |
| Unknown | The Effect of Human Leukocyte Antigen Macthing on Guiding Tacrolimus Regimen After Liver Transplantation NCT03147157 | The First Hospital of Jilin University | N/A |
| Terminated | A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular Syste NCT03098680 | Cambridge University Hospitals NHS Foundation Trust | Phase 1 |
| Completed | Improving Drug Safety in Emergency Patients -a Randomized Controlled Trial NCT03123640 | Diakonhjemmet Hospital | N/A |
| Completed | Side Effects of Anti-PD-(L)-1 and Anti CTLA-A4 in the Non Small Cells Lung Cancer NCT03125603 | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | — |
| Unknown | Investigation of Serious Adverse Events Following Vaccination Against Yellow Fever: Emphasis on Genetic Basis NCT03938597 | The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | — |
| Unknown | Therapeutic Effect of EGF Cream for Cutaneous Adverse Event of EGFR Inhibitors NCT03047863 | The Catholic University of Korea | N/A |
| Unknown | Preventive Effect of EGF Cream for Cutaneous Adverse Event of EGFR Inhibitors NCT03051880 | The Catholic University of Korea | N/A |
| Completed | A Positron Emission Tomography (PET) Imaging Study to Investigate the Biodistribution and Clearance of an Albu NCT02829307 | GlaxoSmithKline | Phase 1 |
| Completed | Acupuncture Prevents Chemobrain in Breast Cancer Patients NCT02457039 | The University of Hong Kong | N/A |
| Unknown | Impact of Clinical Pharmacist on Adverse Drug Events in Older Adults NCT03156348 | University of Chile | N/A |
| Unknown | Acute Care for Elders (ACE) Program at OHSU Hospital NCT02119078 | Oregon Health and Science University | N/A |
| Unknown | Exploratory Study on the Use of Pregabalin for the Treatment of Taxol Related Arthralgia-Myalgia NCT02024568 | Assaf-Harofeh Medical Center | Phase 2 |
| Completed | CYP4A11 and CYP4F2 Gene Variants as Makers of Cardiovascular Adverse Events of Non-steroidal Anti-inflammatory NCT02779530 | Eduardo Barbosa Coelho | Phase 4 |